Q32 Bio Inc. — Director's Dealing 2021

Sep 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2021-09-03

Reporting Person: Kelly Timothy P (See Remarks.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-03	Common Stock	S	54	$7.70	Disposed	0	Direct

Footnotes

F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.

F2: Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021.